DEUS EX MACHINA Expands Ingredient Upscaling Platform Through Pilot Collaborations and Beta Program, Targets Q3 2026 Launch

AI-powered platform advances toward broader market release as select partners join early testing and co-development efforts ATHENS, Greece, April 3, 2026 /PRNewswire/ -- DEUS EX MACHINA, the bioinformatics company specializing in Artificial Intelligence, Machine Learning and Analytics for...